Gujarat Terce Laboratories (BOM:524314) Long-Term Debt: ₹0.3 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:524314 Gujarat Terce Laboratories Ltd BOM:524314
40 GF Score
Price ₹36.36
! 2 Warning Signs
View Full Analysis

What is Gujarat Terce Laboratories Long-Term Debt?

Gujarat Terce Laboratories BOM:524314 -8.53% 40 Long-Term Debt is ₹0.3 Mil as of Mar. 2026. GuruFocus rates BOM:524314 with a GF Score™ of 40/100. The stock has 2 warning signs investors should review.

Gujarat Terce Laboratories's Long-Term Debt for the quarter that ended in Mar. 2026 was ₹0.3 Mil.

Gujarat Terce Laboratories's quarterly Long-Term Debt stayed the same from Sep. 2025 (₹0.0 Mil) to Dec. 2025 (₹0.0 Mil) but then increased from Dec. 2025 (₹0.0 Mil) to Mar. 2026 (₹0.3 Mil).

Gujarat Terce Laboratories's annual Long-Term Debt declined from Mar. 2024 (₹9.3 Mil) to Mar. 2025 (₹3.0 Mil) and declined from Mar. 2025 (₹3.0 Mil) to Mar. 2026 (₹0.3 Mil).

Gujarat Terce Laboratories  (BOM:524314) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Gujarat Terce Laboratories Long-Term Debt Related Terms

Gujarat Terce Laboratories Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Gujarat Terce Laboratories's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gujarat Terce Laboratories Long-Term Debt Chart

Gujarat Terce Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.00 14.61 9.27 2.98 0.30

Gujarat Terce Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.98 0.00 0.00 0.00 0.30
BOM:524314
40GF Score
Gujarat Terce Laboratories Ltd BOM:524314
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of ₹0.3 Mil mean?
Gujarat Terce Laboratories (BOM:524314) has a Long-Term Debt of ₹0.3 Mil as of Mar. 2026.
Is Gujarat Terce Laboratories' Long-Term Debt too high?
Gujarat Terce Laboratories' current Long-Term Debt is ₹0.3 Mil. Overall, Gujarat Terce Laboratories has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Gujarat Terce Laboratories' Long-Term Debt compare to ZTS?
Gujarat Terce Laboratories' Long-Term Debt of ₹0.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Drug Manufacturers company?
A good Long-Term Debt depends on the Drug Manufacturers industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Gujarat Terce Laboratories's current Long-Term Debt is ₹0.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gujarat Terce Laboratories stock overvalued right now?
Gujarat Terce Laboratories (BOM:524314) has a current Long-Term Debt of ₹0.3 Mil. The current Long-Term Debt is ₹0.3 Mil. Gujarat Terce Laboratories' overall GF Score™ is 40/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Gujarat Terce Laboratories (BOM:524314), the current Long-Term Debt is ₹0.3 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Gujarat Terce Laboratories Business Description

Address Near Shivalik High-Street, Unit No. D/801-802 and 1202,The First, Behind Keshavbaug Party Plot, Vastrapur, Ahmedabad, GJ, IND, 380015
Gujarat Terce Laboratories Ltd is an Indian company having business in the medical and pharmaceutical preparations. It is engaged in the manufacturing of tablets, capsules, syrup, and injections. It offers branded as well as generic formulations covering different therapeutic areas such as antibiotics, respiratory, nutraceuticals, gastrointestinal, antifungal, and many more. Some of the main brands are Acolate, Tynol, DFS, Resplash, Aziter, and others.
40GF Score

Get the complete analysis for BOM:524314

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹36.36
Price